bangleshow16 (bangleshow16)

Member for
2 months
Country
Korea, Republic of
Time zone
UTC
Language
Scilab

Randomized Cycle Two Demo involving Carfilzomib-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab inside Superior (Period III-IV) or even Recurrent Uterine Serous Carcinomas that will Overexpress Her2/Neu (NCT01367002): Up-to-date All round Survival Analysis https://www.selleckchem.com/products/incb28060.html

Level
Solved
0
Total
0.00

Level progress

0
1

No solved problems yet.